Compare BKU & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BKU | NVAX |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 1.1B |
| IPO Year | 2011 | 1995 |
| Metric | BKU | NVAX |
|---|---|---|
| Price | $45.13 | $6.75 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 8 |
| Target Price | ★ $42.73 | $9.75 |
| AVG Volume (30 Days) | 1.0M | ★ 3.3M |
| Earning Date | 01-21-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | ★ 44.85 | N/A |
| EPS | ★ 3.54 | 2.07 |
| Revenue | $1,016,093,000.00 | ★ $1,064,651,000.00 |
| Revenue This Year | $14.68 | $58.91 |
| Revenue Next Year | $5.73 | N/A |
| P/E Ratio | $12.80 | ★ $3.22 |
| Revenue Growth | 10.45 | ★ 20.27 |
| 52 Week Low | $28.21 | $5.01 |
| 52 Week High | $46.92 | $11.55 |
| Indicator | BKU | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 64.89 | 43.34 |
| Support Level | $45.33 | $6.36 |
| Resistance Level | $46.33 | $6.76 |
| Average True Range (ATR) | 0.94 | 0.22 |
| MACD | -0.11 | 0.05 |
| Stochastic Oscillator | 44.89 | 47.39 |
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.